A meta ‐analysis of valve‐in‐valve and valve‐in‐ring transcatheter mitral valve implantation

ConclusionsVIV/VIR ‐TMVI brought about relatively low early and midterm (1‐ to 5‐year) mortality, and observed 30‐day mortality was significantly lower than predicted operative mortality.

Source: Journal of Interventional Cardiology - December 5, 2018 Category: Cardiology Authors: Hisato Takagi, Yosuke Hari, Norikazu Kawai, Tomo Ando, for the ALICE (All ‐Literature Investigation of Cardiovascular Evidence) Group Tags: ORIGINAL INVESTIGATION Source Type: research